Lakshman et al. demonstrated that the acquisition of resistance to etoposide-induced apoptosis in CD44-expressing colon cancer cells took place concurrently with alterations in caspase 9, caspase 3, Bcl-xL, and Bak (84). This evidence concerns the gene CD44 and malignant colon neoplasm.